Multicenter phase II trial of vitamin K2 monotherapy and vitamin K2 plus 1α-hydroxyvitamin D3 combination therapy for low-risk myelodysplastic syndromes
Nobu Akiyama, Keisuke Miyazawa, Yoshinobu Kanda, Kaoru Tohyama, Mitsuhiro Omine, Kinuko Mitani, Kazuma OhyashikiVolume:
34
Year:
2010
Language:
english
Pages:
7
DOI:
10.1016/j.leukres.2010.04.006
File:
PDF, 297 KB
english, 2010